Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 9/20 | 0.63 |
| ▸ | HTR2A | P28223 | 8/20 | 0.63 |
| ▸ | HTR2B | P41595 | 7/20 | 0.63 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.53 |
| ▸ | PRCP | P42785 | 5/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1961198 | 0.87 | HTR2C (0.58) | HTR2CHTR2AHTR2BTAAR1PRCP | |
| SCHEMBL4540545 | 0.83 | HTR2C (0.54) | HTR2CHTR2AHTR2BTAAR1PRCP | |
| SCHEMBL163850 | 0.83 | HTR2C (0.57) | HTR2CHTR2AHTR2BTAAR1PRCP | |
| SCHEMBL162669 | 0.83 | HTR2C (0.57) | HTR2CHTR2AHTR2BTAAR1PRCP | |
| SCHEMBL18766048 | 0.83 | HTR2C (0.57) | HTR2CHTR2AHTR2BTAAR1PRCP | |
| SCHEMBL17121746 | 0.82 | MEN1 (0.51) | HTR2CHTR2AHTR2B | |
| SCHEMBL17120414 | 0.82 | MEN1 (0.51) | HTR2CHTR2AHTR2B | |
| SCHEMBL26201345 | 0.82 | MEN1 (0.51) | HTR2CHTR2AHTR2B | |
| Bromide SCHEMBL161200 | 0.81 | HTR2C (0.56) | HTR2CHTR2AHTR2BTAAR1PRCP | |
| Iodide SCHEMBL162026 | 0.81 | HTR2C (0.56) | HTR2CHTR2AHTR2BTAAR1PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2611449-A1 | ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT | Arena Pharmaceuticals, Inc. (US) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012030939-A1 | ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT | ARENA PHARMACEUTICALS, INC. (US) | 2012-03-08 | — | — | WO | disclosed |